Injuries due to taking Fen-Phen demand experienced representation
Fen-Phen was withdrawn in 1997 after the Mayo Clinic reported that 24 patients developed heart valve disease. In one reported study of five Fen-Phen users who underwent valve replacement surgery, the diseased valves were found to have distinctive features similar to those seen in carcinoid syndrome. Soon after, a New England Journal of Medicine article linked Fen-Phen usage to valve disease.
Did you or someone you know take Fen-Phen and suffer adverse side effects? You may be entitled to compensation. Choose an attorney who can put experience and resources to work for clients. Choose the Law Offices of Michael J. Gopin, PLLC. We take aggressive action against insurance companies and demand justice for clients. Call or email our El Paso law firm today for a free and confidential consultation. A delay may affect your rights.
Fen-Phen marketed as anti-obesity drug
Fen-Phen was an anti-obesity drug that consisted of two medications: (Pondimin) fenfluramine and (Ionamin) phentermine.
The FDA in 1997 asked American Home Products (AHP), the makers of Pondimin (Fenfluramine) and Redux (Dexfenfluramine), to withdraw its popular anti-obesity combination Fen-Phen drug from the market. AHP manufactured fenfluramine under the brand name Pondimin and AHP's subsidiary, Wyeth-Ayerst Laboratories, manufactured dexfenfluramine under the name Redux. Medical studies have linked Pondimin and Redux to heart valve disease.
Contact an El Paso lawyer today
A Fen-Phen injury can bring chaos into your life in an instant. Fortunately, the law protects you and your loved ones. We can help you put the pieces back together so you can get on with your life. At the Law Offices of Michael J. Gopin, PLLC, we can help with insurance claims and other paperwork associated with your drug injury. Contact us online today for a free and confidential consultation.
Put the power of an aggressive attorney behind you. Contact the Law Offices of Michael J. Gopin, PLLC. We mean business!